| Identification | Back Directory | [Name]
Propanamide, N-[(3S,5S)-1-[[(3S,4R)-4-(4-chlorophenyl)-1-(1,1-dimethylethyl)-3-pyrrolidinyl]carbonyl]-5-(4-morpholinylcarbonyl)-3-pyrrolidinyl]-2-methyl-N-(cis-4-methylcyclohexyl)-, hydrochloride (1:1) | [CAS]
2641595-55-1 | [Synonyms]
Bivamelagon hydrochloride
Propanamide, N-[(3S,5S)-1-[[(3S,4R)-4-(4-chlorophenyl)-1-(1,1-dimethylethyl)-3-pyrrolidinyl]carbonyl]-5-(4-morpholinylcarbonyl)-3-pyrrolidinyl]-2-methyl-N-(cis-4-methylcyclohexyl)-, hydrochloride (1:1) | [Molecular Formula]
C35H54Cl2N4O4 | [MOL File]
2641595-55-1.mol | [Molecular Weight]
665.74 |
| Hazard Information | Back Directory | [Uses]
MC-4R Agonist 2 hydrochloride (Example 1) is a MC4R agonist. MC-4R Agonist 2 hydrochloride can be used in the study of obesity, diabetes, inflammation, and erectile dysfunction[1]. | [References]
[1] Seung Wan Kang, et al. Melanocortin-4 receptor agonists. Patent WO2021091283A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|